I had fluid next to ovary on CT and had a cyst the week before on US. They said it was not a big deal and was probably the rupture of cyst. I still have lots of wierd fullness down in that area and am freaking out over OC even after US, CT and CA125. I am going back today (6 months later) for another ultrasound and am terrified.
The cysts would have already ruptured if there was fluid. It is qite normal to have cysts every month (small) and they rupture before your period. Many people do not have any symptoms and some have a lot (like me). Good luck.
Sorry, I didn't know you were post menopause. I had very little fluid on CT, and ultrasound the week before which said I had a cyst then and a neg CA125 so my doc and a few others try to assure me I am fine but they also said if it will make me feel better they will do an MRI of abdomen next week. I want it just for piece of mind.
Would anyone happen to know what it means when i have a small amount of fluid found adjacent to my right ovary? The fluid is non specifc, but i'm just worried.
Sarah, the following information does not directly answer your question but gives lots of ovarian cyst info in general. It's from emedicine:
Background: An ovarian cyst is a sac filled with liquid or semiliquid material arising in an ovary. The number of diagnoses of ovarian cysts has increased with the widespread implementation of regular physical examinations and ultrasound technology. The finding of an ovarian cyst causes considerable anxiety for women because of the fear of malignancy, but the vast majority of ovarian cysts are benign.
Pathophysiology: Each month, normally functioning ovaries develop small cysts called graafian follicles. At mid cycle, a single dominant follicle up to 2.8 cm in diameter releases a mature oocyte.
The ruptured follicle becomes the corpus luteum, which, at maturity, is a 1.5- to 2-cm structure with a cystic center. In the absence of fertilization of the oocyte, it undergoes progressive fibrosis and shrinkage. If fertilization occurs, the corpus luteum initially enlarges and then gradually decreases in size during pregnancy.
Ovarian cysts arising in the course of ovarian function are called functional cysts and are always benign. They may be follicular and luteal, sometimes called theca-lutein cysts. These cysts can be stimulated by gonadotrophins, including follicle-stimulating hormone (FSH) and human chorionic gonadotrophin (hCG).
Multiple functional cysts can occur as a result of excessive gonadotrophin stimulation or sensitivity. In gestational trophoblastic neoplasia (hydatidiform mole and choriocarcinoma) and rarely in multiple and diabetic pregnancy, hCG causes a condition called hyperreactio luteinalis. In patients being treated for infertility, ovulation induction with agents such as gonadotrophin-releasing hormone agonists, FSH, hCG, and clomiphene citrate may cause ovarian hyperstimulation syndrome.
Neoplastic cysts arise by inappropriate overgrowth of cells within the ovary and may be malignant or benign. Malignant neoplasms may arise from all ovarian cell types and tissues. By far, the most frequent are those arising from the surface epithelium (mesothelium), and most of these are partially cystic lesions. The benign counterparts of these cancers are serous and mucinous cystadenomas. Other malignant ovarian tumors may contain cystic areas, and these include granulosa cell tumors from sex cord stromal cells and germ cell tumors from primordial germ cells. Teratomas are a form of germ cell tumor containing elements from all 3 embryonic germ layers, ie, ectoderm, endoderm, and mesoderm.
In the US: Ovarian cysts are found on transvaginal ultrasound images in nearly all premenopausal women and in up to 14.8% of postmenopausal women. The majority of these cysts are functional in nature and benign. Mature cystic teratomas or dermoids represent more than 10% of all ovarian neoplasms. The incidence of ovarian carcinoma is approximately 15 cases per 100,000 women per year. Estimates indicate that in 2002, 23,300 women will be diagnosed and 13,900 women will die of ovarian carcinoma in the United States. Most malignant ovarian tumors are epithelial ovarian cystadenocarcinomas. Tumors of low malignant potential comprise approximately 20% of malignant ovarian tumors, fewer than 5% of malignant germ cell tumors, and approximately 2% of granulosa cell tumors.
Benign cysts can cause pain and discomfort related to pressure on adjacent structures, torsion, rupture, hemorrhage (both within and outside of the cyst), and abnormal uterine bleeding. They rarely cause death. Mucinous cystadenomas can cause a relentless collection of mucinous fluid within the abdomen, known as pseudomyxoma peritonei, which frequently is fatal.
Mortality associated with malignant ovarian carcinoma is related to the stage at the time of diagnosis, and patients with ovarian carcinoma generally present late in the course of disease. The 5-year survival rate overall is 41.6%, varying between 86.9% for International Federation of Gynecology and Obstetrics (FIGO) stage 1a and 11.1% for stage IV. Granulosa cell tumors are associated with an 82% survival rate, whereas squamous cell carcinomas arising in a dermoid cyst have a very poor outcome. Most germ cell tumors are diagnosed at an early stage and have an excellent outcome. Advanced-stage dysgerminomas are associated with a better outcome compared to nondysgerminomatous germ cell tumors. A distinct group of less aggressive tumors of low malignant potential has a more benign course but is still associated with mortality.
Malignant ovarian cystic tumors can cause severe morbidity, including pain, abdominal distension, bowel obstruction, nausea, vomiting, early satiety, wasting, cachexia, indigestion, heartburn, abnormal uterine bleeding, deep venous thrombosis, and dyspnea. Cystic granulosa cell tumors may secrete estrogen, which leads to postmenopausal bleeding and precocious puberty in elderly patients and young patients, respectively.
Functional ovarian cysts occur at any age (including in utero), but are much more common in reproductive-aged women. They are rare after menopause. Luteal cysts occur after ovulation in reproductive-aged women. Most benign neoplastic cysts occur during the reproductive years, but the age range is wide and they may occur in persons of any age.
The incidence of epithelial ovarian cystadenocarcinomas, sex cord stromal tumors, and mesenchymal tumors rises exponentially with age until the sixth decade of life, at which point incidence plateaus. Tumors of low malignant potential occur at a mean age of 44 years, with a span from adolescence to senescence. The average age is more than a decade less than that for invasive cystadenocarcinoma. Germ cell tumors are most common in adolescence and rarely occur in those older than 30 years.
The majority of ovarian cysts are asymptomatic. Even malignant ovarian cysts commonly do not cause symptoms until they reach an advanced stage.
Pain or discomfort may occur in the lower abdomen. Torsion or rupture may lead to more severe pain.
Patients may experience discomfort with intercourse, particularly deep penetration. Having bowel movements may be difficult, or pressure may develop, leading to a desire to defecate.
Irregularity of the menstrual cycle and abnormal vaginal bleeding may occur.
Patients may experience abdominal fullness and bloating.
Patients may experience indigestion, heartburn, or early satiety.
Endometriomas are associated with endometriosis, which causes a classic triad of painful and heavy periods and dyspareunia.
Polycystic ovaries may be part of the polycystic ovary syndrome (PCOS), which includes hirsutism, infertility, oligomenorrhea, obesity, and acne.
Advanced malignant disease may be associated with cachexia and weight loss, lymphadenopathy in the neck, shortness of breath, and signs of pleural effusion.
A large cyst may be palpable during the abdominal examination. Gross ascites may interfere with palpation of an intra-abdominal mass.
Although normal ovaries may be palpable during the pelvic examination in thin premenopausal patients, a palpable ovary should be considered abnormal in a postmenopausal woman. If a patient is obese, palpating cysts of any size may prove difficult.
Sometimes, discerning the cystic nature of an ovarian cyst may be possible, and it may be tender to palpation. The cervix and uterus may be pushed to one side.
Other masses may be palpable, including fibroids and nodules in the uterosacral ligament consistent with malignancy or endometriosis.
Multiple functional cysts can occur as a result of excessive gonadotrophin stimulation or sensitivity. Tamoxifen and clomiphene citrate can cause benign functional ovarian cysts that usually resolve following discontinuation of treatment.Risk factors for ovarian cystadenocarcinoma include strong family history, advancing age, white race, infertility, nulliparity, a history of breast cancer, and BRCA gene mutations.